Key facts
- This page summarizes Luis C. Pena's Form 4 filing for Evommune, Inc. (EVMN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 Oct 2026, 16:28.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Represents shares acquired under the non-qualified component of the Evommune, Inc. 2025 Employee Stock Purchase Plan ("ESPP").
Footnote F2
In accordance with current ESPP offering standards, these shares were purchased at 85% of the closing price of the Issuer's common stock on September 30, 2026.
SEC remarks
This transaction is being reported late due to an administrative oversight.